UPDATE : Monday, June 25, 2018
Hugel completes P1 clinical trial on hypertrophic scar treatment
Hugel said Wednesday that it has completed phase 1 clinical trials on BMT10...
by Lee Han-soo  |  2018-05-17 11:50
Dongwha, Hugel boost Q1 earnings under new CEO
Seven drugmakers with new CEOs this year showed mixed results in the first-...
by So Jae-hyeon  |  2018-05-17 11:45
Allergan Korea appoints Kim Ji-hyun as new CEO
Allergan appointed Kim Ji-hyun as the new CEO of its Korean offshoot. Kim h...
by Marian Chu  |  2018-05-17 11:36
US approves Daewoong’s Nabota plant
Daewoong Pharmaceutical said it got the U.S. Food and Drug Administration’s...
by Marian Chu  |  2018-05-16 18:34
‘Biosimilars are better than originals’
“Biosimilars offer better quality than original drugs. This is a fact.”Jean...
by Park Gi-taek  |  2018-05-16 15:56
Jeil Pharma opens new tech research center
Jeil Pharmaceutical said Wednesday that it has opened a new technology rese...
by Lee Han-soo  |  2018-05-16 14:14
Warm inter-Korean relations may benefit GC Pharma, Dong-A ST
The South Korean pharmaceutical industry is paying keen attention to which ...
by So Jae-hyeon  |  2018-05-15 15:50
Dongkook to export hyaluronic acid filler to China
Dongkook Pharmaceutical said Monday that it has signed a 16 billion won ($1...
by Lee Han-soo  |  2018-05-15 15:21
Huons Global posts ₩85.8 billion in Q1 sales
Huons Global said Tuesday the company and its subsidiaries recorded 85.8 bi...
by Lee Han-soo  |  2018-05-15 14:59
Medytox posts ₩58.8 billion in Q1 sales
Medytox said Tuesday that it recorded 58.8 billion won ($54.9 million) in s...
by Lee Han-soo  |  2018-05-15 14:59
Merck’s Erbitux extends RSA status
Merck Korea and the health authorities have renewed their risk-sharing agre...
by Nam Doo-hyun  |  2018-05-15 14:31
Alteogen to launch global P1 trial of Eylea biosimilar in 2019
Alteogen has wrapped up the pre-clinical trial for ALT-L9 - an Eylea biosim...
by Marian Chu  |  2018-05-15 11:26
Ildong wins nod for hypertension treatment
Ildong Pharmaceutical said Monday that it has received sales approval for T...
by Lee Han-soo  |  2018-05-14 16:50
Pharmbio to market Trevena’s narcotic analgesic exclusively
Pharmbio Korea CEO Nam Bong-gil (left) and Trevena CEO Maxine Gowen shake h...
by Lee Han-soo  |  2018-05-14 15:06
Handok unveils trial results for diabetes treatment
Handok held a symposium to present the mid-term trial results for Tenelia T...
by Lee Han-soo  |  2018-05-14 15:05
GSK’s 3-in-1 inhaler for COPD arrives in Korea
GlaxoSmithKline’s triple drug inhaler for the treatment of chronic obstruct...
by Lee Hye-seon  |  2018-05-14 14:54
‘FDA is adapting to fast-changing digital healthcare’
The Korean healthcare system and regulations need to change, in line with t...
by So Jae-hyeon  |  2018-05-11 16:22
Daewoong, CJ, Jeil win nod for combo drug for dyslipidemia, diabetes
Daewoong Pharmaceutical, CJ Healthcare, and Jeil Pharmaceutical have won th...
by Lee Hye-seon  |  2018-05-11 14:37
Bukwang releases new dosage form of Tacenol
Tacenol Bukwang Pharmaceutical said Thursday that it has released Tacenol...
by Lee Han-soo  |  2018-05-11 11:34
‘Breast cancer drug Faslodex needs insurance coverage’
AstraZeneca Korea’s breast cancer treatment Faslodex (ingredient: fulvestra...
by Nam Doo-hyun  |  2018-05-11 11:31
Back to Top